jRCT1030260304招募中不适用
A Multi-center, single-blind, Randomized Controlled Trial Comparing Interrupted vs Continuous Fascial Closure in the Mini-laparotomy Incision During Laparoscopic or Robot-assisted Colorectal Resection (CLOSURE-CR trial)
未提供0 个研究点目标入组 900 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 No limit(—)
- 性别
- All
入选标准
- •Patients who meet all of the following inclusion criteria and none of the exclusion criteria will be considered eligible for enrollment.
- •Inclusion Criteria
- •1.Patients with neoplastic lesions of the colon (including colorectal cancer, appendiceal tumors, neuroendocrine tumors, gastrointestinal stromal tumors, etc.) who are scheduled to undergo curative resection, and for whom laparoscopic or robot-assisted colorectal resection is planned.
- •2.Patients for whom a small midline laparotomy incision including the umbilicus is planned for bowel transection, anastomosis, and specimen retrieval.
- •3.Patients with an ECOG Performance Status (PS) of 0, 1, or
- •4.Patients aged 18 years or older at the time of registration.
- •5.Patients who are scheduled to undergo an abdominal CT scan at approximately 1 year postoperatively, or for whom such imaging is considered feasible.
- •6.Patients with preserved function of major organs (including bone marrow, liver, kidney, and lungs) meeting the following criteria:
- •A) White blood cell count: >=2,000mm3 and <=15,000mm3
- •B) Hemoglobin: >=7.5 g/dL
- •C) Platelet count: >=75,000/mm3
- •D) Total bilirubin: <=2.0 mg/dL
- •E) Creatinine: <=2.0 mg/dL
- •7.Patients who have sufficient capacity to understand the study and have provided written informed consent.
排除标准
- •1.Patients with umbilical hernia or incisional abdominal wall hernia at the planned umbilical incision site, as identified on preoperative imaging.
- •2.Patients scheduled to undergo emergency surgery.
- •3.Patients with active infections requiring systemic treatment.
- •4.Patients with a body temperature of >=38.0 degrees Celsius at the time of registration.
- •5.Patients with psychiatric disorders or symptoms that interfere with daily life and are judged to make participation in the study difficult.
- •6.Women who are pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding.
- •7.Patients who are scheduled to undergo abdominal surgery within 6 months after registration (e.g., planned surgery for metastatic liver tumors as a staged resection).
研究者
相似试验
招募中
不适用
A Prospective Comparative Study Evaluating the Effectiveness of a Novel Endoscopic Resection Technique (Tip-in UEMR) for Superficial Duodenal Tumors Measuring 10-20 mmSuperficial non-ampullary duodenal epithelial tumor (SNADET)jRCT105225018376
尚未招募
不适用
A study to evaluate the efficacy and safety of ELGN-2112 on intestinal malabsorption in preterm infants as compared to placebo. (FIT-PIV)Intestinal Malabsorption in Preterm InfantsjRCT203126028220
尚未招募
不适用
Minimally Invasive Radical Hysterectomy Using Endoscopic Stapler in Stage IB2 or IIA1 Cervical CancerNCT07256977Seoul National University Hospital494
尚未招募
不适用
A study comparing different wound closure methods to prevent infection after colorectal cancer surgery (Wound Closure Study)Colorectal cancerjRCT10402600082,000
招募中
1 期
A Single-Center, Double-Blind, Randomized, Placebo Controlled Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses of ACI-19764 in Healthy Participants2025-523885-25-00AC Immune S.A.78
